Form 8-K - Current report:
SEC Accession No. 0000950123-08-009835
Filing Date
2008-08-18
Accepted
2008-08-18 16:04:30
Documents
2
Period of Report
2008-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y65737e8vk.htm 8-K 14074
2 EX-99.1: SECOND AMENDMENT TO CONSENT SOLICITATION STATEMENT y65737exv99w1.htm EX-99.1 4652
  Complete submission text file 0000950123-08-009835.txt   20543
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12957 | Film No.: 081025210
SIC: 2836 Biological Products, (No Diagnostic Substances)